Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Palatin Technologies Inc
PTNCurrent price
1.3 USD
+0.13 USD (+11.11%)
Last closed
1.16 USD
Company
palatin.com
ISIN
US6960774031
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Capitalization
23 457 840 USD
Yield for 12 month
-32.29 %
1Y
3Y
5Y
10Y
15Y
PTN
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey. Address: Cedar Brook Corporate Center, Cranbury, NJ, United States, 08512
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
17 USDP/E ratio
–Dividend Yield
–Current Year
+4 490 090 USD
Last Year
+4 853 678 USD
Current Quarter
+350 000 USD
Last Quarter
–
Current Year
+4 392 453 USD
Last Year
+4 435 208 USD
Current Quarter
+180 092 USD
Last Quarter
-171 789 USD
Key Figures PTN
1 year
3 years
5 years
10 years
EBITDA
-29 938 890 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-131.96 %
PEG Ratio
–
Return On Equity TTM
-623.2 %
Wall Street Target Price
17 USD
Revenue TTM
4 490 090 USD
Book Value
-0.006 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-80.1 %
Dividend Yield
–
Gross Profit TTM
-18 195 369 USD
Earnings per share
-2.02 USD
Diluted Eps TTM
-2.02 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics PTN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PTN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:25
Payout Ratio
–
Last Split Date
31.08.2022
Dividend Date
–
Stock Valuation PTN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.234
Price Sales TTM
5.2244
Enterprise Value EBITDA
-0.6433
Price Book MRQ
15.8257
Financials PTN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PTN
For 52 weeks
0.68 USD
5.65 USD
50 Day MA
1.19 USD
Shares Short Prior Month
1 318 578
200 Day MA
1.93 USD
Short Ratio
2.96
Shares Short
1 266 237
Short Percent
6.63 %
BeatStart